Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.
Company profile
Ticker
BSX
Exchange
Website
CEO
Michael Mahoney
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Acotec Scientific Holdings Limited • Acurate Industria e Comercio Ltda. • American Medical Systems Europe B.V. • Apollo Endosurgery Australia Pty Ltd • Apollo Endosurgery Brasil Aparelhos Cirurgicos Ltda. • Apollo Endosurgery Canada Ltd. • Apollo Endosurgery Costa Rica, S.R.L. • Apollo Endosurgery International, LLC • Apollo Endosurgery UK Ltd • Apollo Endosurgery US, Inc. ...
IRS number
42695240
BSX stock data
Latest filings (excl ownership)
8-K
Boston Scientific Announces Results for First Quarter 2024
24 Apr 24
8-K
Other Events
4 Apr 24
DEFA14A
Additional proxy soliciting materials
20 Mar 24
DEF 14A
Definitive proxy
20 Mar 24
ARS
2023 FY
Annual report to shareholders
20 Mar 24
PRE 14A
Preliminary proxy
7 Mar 24
8-K
Entry into a Material Definitive Agreement
27 Feb 24
424B2
Prospectus for primary offering
23 Feb 24
FWP
Free writing prospectus
22 Feb 24
424B5
Prospectus supplement for primary offering
22 Feb 24
Transcripts
BSX
Earnings call transcript
2024 Q1
24 Apr 24
BSX
Earnings call transcript
2023 Q4
31 Jan 24
BSX
Earnings call transcript
2023 Q3
26 Oct 23
BSX
Earnings call transcript
2023 Q2
27 Jul 23
BSX
Earnings call transcript
2023 Q1
26 Apr 23
BSX
Earnings call transcript
2022 Q4
1 Feb 23
BSX
Earnings call transcript
2022 Q3
26 Oct 22
BSX
Earnings call transcript
2022 Q2
27 Jul 22
BSX
Earnings call transcript
2022 Q1
27 Apr 22
BSX
Earnings call transcript
2021 Q4
2 Feb 22
Latest ownership filings
144
Notice of proposed sale of securities
26 Apr 24
4
John Bradley Sorenson
2 Apr 24
4
Wendy Carruthers
2 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
4
Jeffrey B. Mirviss
19 Mar 24
144
Notice of proposed sale of securities
18 Mar 24
4/A
Eric Francis Yves Thepaut
11 Mar 24
4
Emily Woodworth
5 Mar 24
3
Emily Woodworth
5 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q3 2023
89.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1025 |
Opened positions | 110 |
Closed positions | 102 |
Increased positions | 424 |
Reduced positions | 331 |
13F shares | Current |
---|---|
Total value | 68.96 tn |
Total shares | 1.32 bn |
Total puts | 8.49 mm |
Total calls | 6.69 mm |
Total put/call ratio | 1.3 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 129.31 mm | $6.83 tn |
FMR | 125.92 mm | $6.65 tn |
Vanguard | 123.77 mm | $6.53 tn |
Massachusetts Financial Services | 62.53 mm | $3.30 tn |
STT State Street | 61.95 mm | $3.27 tn |
Wellington Management | 42.08 mm | $2.22 tn |
Primecap Management | 37.36 mm | $1.97 tn |
Geode Capital Management | 27.00 mm | $1.42 tn |
BAC Bank Of America | 25.29 mm | $1.34 tn |
JPM JPMorgan Chase & Co. | 24.10 mm | $1.27 tn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | John Bradley Sorenson | Common Stock | Sell | Dispose S | No | Yes | 69.2966 | 16,351 | 1.13 mm | 50,638 |
1 Apr 24 | John Bradley Sorenson | Common Stock | Option exercise | Acquire M | No | Yes | 16.31 | 16,351 | 266.68 k | 66,989 |
1 Apr 24 | John Bradley Sorenson | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 16.31 | 16,351 | 266.68 k | 0 |
1 Apr 24 | Wendy Carruthers | Common Stock | Sell | Dispose S | No | Yes | 68.42 | 6,983 | 477.78 k | 51,068 |
1 Apr 24 | Wendy Carruthers | Common Stock | Option exercise | Acquire M | No | Yes | 24.55 | 1,197 | 29.39 k | 58,051 |
1 Apr 24 | Wendy Carruthers | Common Stock | Option exercise | Acquire M | No | Yes | 17.26 | 3,066 | 52.92 k | 56,854 |
1 Apr 24 | Wendy Carruthers | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 24.55 | 1,197 | 29.39 k | 22,759 |
1 Apr 24 | Wendy Carruthers | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 17.26 | 3,066 | 52.92 k | 24,528 |
18 Mar 24 | Jeffrey B. Mirviss | Common Stock | Sell | Dispose S | No | Yes | 66.4504 | 14,506 | 963.93 k | 58,098 |
1 Mar 24 | Wendy Carruthers | Common Stock | Sell | Dispose S | No | Yes | 66.35 | 6,983 | 463.32 k | 53,788 |
News
Barclays Maintains Overweight on Boston Scientific, Raises Price Target to $78
26 Apr 24
Top 4 Health Care Stocks That May Plunge This Month
26 Apr 24
Citigroup Maintains Buy on Boston Scientific, Raises Price Target to $85
25 Apr 24
(BSX) - Analyzing Boston Scientific's Short Interest
25 Apr 24
Deutsche Bank Maintains Hold on Boston Scientific, Raises Price Target to $73
25 Apr 24
Press releases
Volato Announces Changes to Board Composition
24 Apr 24
Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module
8 Apr 24
Scivita Medical Expands Collaboration with Boston Scientific
25 Mar 24
Axonics Stockholders Approve Merger Agreement with Boston Scientific
22 Mar 24
Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon
1 Mar 24